Kamada Ltd. (KMDA) Reports Second Quarter Financial Results
8/14/2014 8:10:08 AM
NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces financial results for the three and six months ended June 30, 2014.
Financial highlights of the second quarter of 2014 and recent weeks include:
* Revenues for the quarter were $15.8 million compared with $16.1 million for the second quarter of 2013; the second quarter of 2013 included a one-time payment of $4.5 million received from Baxter International Inc. (Baxter) related to a technology transfer milestone
Help employers find you! Check out all the jobs and post your resume.
comments powered by